A Multicenter Study to Evaluate the ROX Arteriovenous Coupler in Patients With Treatment-Resistant Hypertension

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 100 participants.

Also called NCT01642498

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
ROX Medical, Inc. (from the registry)
Registry
  • NCT NCT01642498
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Germany, Greece, Ireland, Netherlands, Poland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01642498. Randomized; no masking; primary purpose treatment. Start 2012-09-01 (actual); primary completion 2018-06-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Multicenter Study to Evaluate the ROX Arteriovenous Coupler in Patients With Treatment-Resistant Hypertension
Condition
Hypertension
Intervention (Device)
ROX COUPLER
Lead sponsor
ROX Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01642498
Content hash
4fc4be5a69cda1ec586e193a3e49a9d739f32141cf258c1e9b67ee436b09fb67